Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winfried Brenner

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
EJNMMI Research|February 24, 2019
Diffusion-weighted magnetic resonance imaging using a preclinical 1 T PET/MRI in healthy and tumor-bearing ratsJakob Albrecht, Dietrich Polenz, Anja A Kühl, et al.
International Journal of Biological Macromolecules|March 4, 2025
Long circulating XTEN864-HGV-Apoptin fusion protein for selective cancer therapyLiu Yang, Akvile Haeckel, Nicola Beindorff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancerCorinna von Forstner, Jan-Hendrik Egberts, Ole Ammerpohl, et al.
EJNMMI Radiopharmacy and Chemistry|November 20, 2023
Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for <sup>68</sup>Ga, <sup>177</sup>Lu and <sup>198</sup>AuAnna Baitullina, Guilhem Claude, Suelen F Sucena, et al.
Theranostics|October 8, 2019
CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancerSarah Erdmann, Lars Niederstadt, Eva Jolanthe Koziolek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2021
<sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital HyperinsulinismMarti Boss, Christof Rottenburger, Winfried Brenner, et al.
Neoplasia (New York, N.Y.)|November 27, 2020
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivoFranziska Briest, Eva J Koziolek, Jakob Albrecht, et al.
EJNMMI Research|August 12, 2025
[<sup>68</sup>Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinismPeter Kühnen, Sonal Prasad, Karin Rothe, et al.
European Heart Journal. Cardiovascular Imaging|January 11, 2022
Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterizationThomas H Wurster, Ulf Landmesser, Youssef S Abdelwahed, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric InpatientsKerstin Ritter, Catharina Lange, Martin Weygandt, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
EJNMMI Research|February 24, 2019
Diffusion-weighted magnetic resonance imaging using a preclinical 1 T PET/MRI in healthy and tumor-bearing ratsJakob Albrecht, Dietrich Polenz, Anja A Kühl, et al.
International Journal of Biological Macromolecules|March 4, 2025
Long circulating XTEN864-HGV-Apoptin fusion protein for selective cancer therapyLiu Yang, Akvile Haeckel, Nicola Beindorff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancerCorinna von Forstner, Jan-Hendrik Egberts, Ole Ammerpohl, et al.
EJNMMI Radiopharmacy and Chemistry|November 20, 2023
Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for <sup>68</sup>Ga, <sup>177</sup>Lu and <sup>198</sup>AuAnna Baitullina, Guilhem Claude, Suelen F Sucena, et al.
Theranostics|October 8, 2019
CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancerSarah Erdmann, Lars Niederstadt, Eva Jolanthe Koziolek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2021
<sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital HyperinsulinismMarti Boss, Christof Rottenburger, Winfried Brenner, et al.
Neoplasia (New York, N.Y.)|November 27, 2020
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivoFranziska Briest, Eva J Koziolek, Jakob Albrecht, et al.
EJNMMI Research|August 12, 2025
[<sup>68</sup>Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinismPeter Kühnen, Sonal Prasad, Karin Rothe, et al.
European Heart Journal. Cardiovascular Imaging|January 11, 2022
Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterizationThomas H Wurster, Ulf Landmesser, Youssef S Abdelwahed, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric InpatientsKerstin Ritter, Catharina Lange, Martin Weygandt, et al.
Pageof 17